Orleans Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Buy |
6,317
+1,085
| +21% | +$440K | 1.36% | 27 |
|
|
2025
Q1 | $2.6M | Sell |
5,232
-13
| -0.2% | -$6.47K | 1.53% | 26 |
|
|
2024
Q4 | $2.86M | Sell |
5,245
-30
| -0.6% | -$16.4K | 1.6% | 24 |
|
|
2024
Q3 | $3.26M | Sell |
5,275
-100
| -2% | -$61.9K | 1.85% | 16 |
|
|
2024
Q2 | $2.97M | Sell |
5,375
-115
| -2% | -$63.6K | 1.89% | 20 |
|
|
2024
Q1 | $3.19M | Sell |
5,490
-575
| -9% | -$334K | 2.1% | 16 |
|
|
2023
Q4 | $3.22M | Buy |
6,065
+245
| +4% | +$130K | 2.16% | 17 |
|
|
2023
Q3 | $2.95M | Sell |
5,820
-210
| -3% | -$106K | 2.19% | 13 |
|
|
2023
Q2 | $3.15M | Sell |
6,030
-75
| -1% | -$39.1K | 2.23% | 13 |
|
|
2023
Q1 | $3.52M | Sell |
6,105
-85
| -1% | -$49K | 2.6% | 9 |
|
|
2022
Q4 | $3.41M | Buy |
6,190
+5
| +0.1% | +$2.75K | 2.61% | 12 |
|
|
2022
Q3 | $3.14M | Sell |
6,185
-285
| -4% | -$145K | 2.62% | 10 |
|
|
2022
Q2 | $3.52M | Buy |
6,470
+30
| +0.5% | +$16.3K | 2.63% | 9 |
|
|
2022
Q1 | $3.8M | Buy |
6,440
+20
| +0.3% | +$11.8K | 2.36% | 11 |
|
|
2021
Q4 | $4.28M | Buy |
6,420
+50
| +0.8% | +$33.4K | 2.43% | 12 |
|
|
2021
Q3 | $3.64M | Sell |
6,370
-60
| -0.9% | -$34.3K | 2.32% | 12 |
|
|
2021
Q2 | $3.24M | Sell |
6,430
-50
| -0.8% | -$25.2K | 2.08% | 17 |
|
|
2021
Q1 | $2.96M | Buy |
6,480
+75
| +1% | +$34.2K | 2.01% | 19 |
|
|
2020
Q4 | $2.98M | Sell |
6,405
-55
| -0.9% | -$25.6K | 2.14% | 16 |
|
|
2020
Q3 | $2.85M | Buy |
6,460
+75
| +1% | +$33.1K | 2.18% | 16 |
|
|
2020
Q2 | $2.31M | Buy |
+6,385
| New | +$2.31M | 1.89% | 17 |
|
|
2020
Q1 | – | Sell |
-5,410
| Closed | -$1.76M | – | 82 |
|
|
2019
Q4 | $1.76M | Buy |
5,410
+320
| +6% | +$104K | 1.23% | 36 |
|
|
2019
Q3 | $1.48M | Buy |
5,090
+425
| +9% | +$124K | 1.1% | 43 |
|
|
2019
Q2 | $1.37M | Buy |
+4,665
| New | +$1.37M | 1.03% | 41 |
|